Back to news
2020-11-16

Proud to Attend ISPOR Europe 2020 Virtual Conference!

Proud to Attend ISPOR Europe 2020 Virtual Conference!

PeriPharm is proud to attend and present some collaborations at the ISPOR 2020 virtual conference which will be held from November 16 to 19.

  • Beauchemin C, Charron JN, Mathurin K, Jobin Gervais K, Barbeau M, Agoumi Y. Cost per Responder Analysis of Latanoprostene Bunod Compared to Prostaglandin Analogs for Open-Angle Glaucoma in Canada. International Society for Pharmacoeconomics and Outcomes Research (ISPOR) (pp PSS5), Nov. 2020, Milan, Italy (virtual meeting) link

  • Beauchemin C, Guinan K, Mathurin K, Dufresne SF, Rotstein C, Claveau D, Landry L, Lachaine J. Isavuconazole for the Treatment of Invasive Aspergillosis and Mucormycosis- A Canadian Cost-Utility Analysis. International Society for Pharmacoeconomics and Outcomes Research (ISPOR) (pp PIN44), Nov. 2020, Milan, Italy (virtual meeting) link

  • Lachaine J, Charron JN, Gregoire JC, Hegele RA, Leiter LA. Cost-Effectiveness of Icosapent Ethyl (IPE) for the Reduction of the Risk of Ischemic Cardiovascular Events in Canada. International Society for Pharmacoeconomics and Outcomes Research (ISPOR) (pp PCV55), Nov. 2020, Milan, Italy (virtual meeting) link